A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Role of cytochrome P450 polymorphisms in the development of pulmonary drug toxicity: a case-control study in the Netherlands.
Petal A H M Wijnen, Marjolein Drent, Patty J Nelemans, Petra M J C Kuijpers, Ger H Koek, Cees Neef, Guido R M M Haenen, Otto Bekers. Drug Saf 2008
25
100


36
100

Clinical implications of pharmacogenetic variation on the effects of statins.
Simran D S Maggo, Martin A Kennedy, David W J Clark. Drug Saf 2011
44
100


Managing the underestimated risk of statin-associated myopathy.
Loukianos S Rallidis, Katerina Fountoulaki, Maria Anastasiou-Nana. Int J Cardiol 2012
61
100

Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors.
H Fujino, T Saito, Y Tsunenari, J Kojima, T Sakaeda. Xenobiotica 2004
81
100

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
100


Statin use and musculoskeletal pain among adults with and without arthritis.
Catherine Buettner, Matthew J Rippberger, Julie K Smith, Suzanne G Leveille, Roger B Davis, Murray A Mittleman. Am J Med 2012
74
100


Pharmacogenomics of statins: understanding susceptibility to adverse effects.
Joseph P Kitzmiller, Eduard B Mikulik, Anees M Dauki, Chandrama Murkherjee, Jasmine A Luzum. Pharmgenomics Pers Med 2016
46
100

Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin.
Piergiorgio Zuccaro, Giuliana Mombelli, Laura Calabresi, Damiano Baldassarre, Ilaria Palmi, Cesare R Sirtori. Pharmacol Res 2007
52
100

Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity.
Dhiaa A Taha, Atheer Zgair, Jong Bong Lee, Cornelia H de Moor, David A Barrett, Kimberley D Bruce, Mitchell Sungelo, Robert H Eckel, Pavel Gershkovich. Eur J Pharm Sci 2017
7
100

Drug-induced interstitial lung disease: role of pharmacogenetics in predicting cytotoxic mechanisms and risks of side effects.
Naomi T Jessurun, Marjolein Drent, Eugène P van Puijenbroek, Otto Bekers, Petal A Wijnen, Aalt Bast. Curr Opin Pulm Med 2019
8
100

Impact of OATP transporters on pharmacokinetics.
A Kalliokoski, M Niemi. Br J Pharmacol 2009
626
100

Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies.
Dhiaa A Taha, Cornelia H De Moor, David A Barrett, Pavel Gershkovich. Transl Res 2014
37
100

Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease.
Wim A Wuyts, Marlies Wijsenbeek, Benjamin Bondue, Demosthenes Bouros, Paul Bresser, Carlos Robalo Cordeiro, Ole Hilberg, Jesper Magnusson, Effrosyni D Manali, António Morais,[...]. Respiration 2020
40
100

Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations.
Aurel C Allabi, Jean-Luc Gala, Jean-Pierre Desager, Michel Heusterspreute, Yves Horsmans. Br J Clin Pharmacol 2003
91
100

Spectrum of Fibrotic Lung Diseases.
Marlies Wijsenbeek, Vincent Cottin. N Engl J Med 2020
161
100

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.
Eric Bruckert, Gilles Hayem, Sylvie Dejager, Caroline Yau, Bernard Bégaud. Cardiovasc Drugs Ther 2005
831
100

Interpretation of the evidence for the efficacy and safety of statin therapy.
Rory Collins, Christina Reith, Jonathan Emberson, Jane Armitage, Colin Baigent, Lisa Blackwell, Roger Blumenthal, John Danesh, George Davey Smith, David DeMets,[...]. Lancet 2016
993
100

Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
Loredana Serpe, Roberto Canaparo, Maria Gabriella Scordo, Edoardo Spina. Drug Metab Pers Ther 2015
8
100


Screening for Early Signs of Paternal Perinatal Affective Disorder in Expectant Fathers: A Cluster Analysis Approach.
Sonia Mangialavori, Michele Giannotti, Marco Cacioppo, Federico Spelzini, Franco Baldoni. J Pers Med 2020
8
100

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
Marja K Pasanen, Mikko Neuvonen, Pertti J Neuvonen, Mikko Niemi. Pharmacogenet Genomics 2006
359
100

The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers.
W J Tamminga, J Wemer, B Oosterhuis, R A de Zeeuw, L F de Leij, J H Jonkman. Eur J Clin Pharmacol 2001
75
100

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs.
D Wang, Y Guo, S A Wrighton, G E Cooke, W Sadee. Pharmacogenomics J 2011
346
100

Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach.
José V Castell, M Teresa Donato, María José Gómez-Lechón. Exp Toxicol Pathol 2005
147
100

Statins: Adverse reactions, oxidative stress and metabolic interactions.
Aimei Liu, Qinghua Wu, Jingchao Guo, Irma Ares, José-Luis Rodríguez, María-Rosa Martínez-Larrañaga, Zonghui Yuan, Arturo Anadón, Xu Wang, María-Aránzazu Martínez. Pharmacol Ther 2019
50
100

Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms.
Takeshi Hirota, Hiroshi Takane, Shun Higuchi, Ichiro Ieiri. Curr Drug Metab 2008
24
100

National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.
Joseph A Salami, Haider Warraich, Javier Valero-Elizondo, Erica S Spatz, Nihar R Desai, Jamal S Rana, Salim S Virani, Ron Blankstein, Amit Khera, Michael J Blaha,[...]. JAMA Cardiol 2017
225
100

Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients.
Josephine H Li, Scott V Joy, Susanne B Haga, Lori A Orlando, William E Kraus, Geoffrey S Ginsburg, Deepak Voora. J Pers Med 2014
27
100



The role of acid-base imbalance in statin-induced myotoxicity.
Dhiaa A Taha, Cornelia H De Moor, David A Barrett, Jong Bong Lee, Raj D Gandhi, Chee Wei Hoo, Pavel Gershkovich. Transl Res 2016
25
100

Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin.
A B Mulder, H J van Lijf, M A Bon, F A van den Bergh, D J Touw, C Neef, I Vermes. Clin Pharmacol Ther 2001
94
100

Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy.
Philippe Couvert, Philippe Giral, Sylvie Dejager, Jessie Gu, Thierry Huby, M John Chapman, Eric Bruckert, Alain Carrié. Pharmacogenomics 2008
63
100

Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
Matthew Silva, Michele L Matthews, Courtney Jarvis, Nicole M Nolan, Paul Belliveau, Michael Malloy, Pritesh Gandhi. Clin Ther 2007
147
100

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.
Jin-Fu Xu, George R Washko, Kiichi Nakahira, Hiroto Hatabu, Avignat S Patel, Isis E Fernandez, Mizuki Nishino, Yuka Okajima, Tsuneo Yamashiro, James C Ross,[...]. Am J Respir Crit Care Med 2012
106
100

The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6.
Thomayant Prueksaritanont, Bennett Ma, Nathan Yu. Br J Clin Pharmacol 2003
139
100

Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels-A prospective pharmacokinetic study.
Naomi T Jessurun, Annemieke Vermeulen Windsant, Oenone Mikes, Eugène P van Puijenbroek, Rob J van Marum, Koen Grootens, Hieronymus J Derijks. Br J Clin Pharmacol 2021
1
100

Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.
Eveline Jaquenoud Sirot, Jan Willem van der Velden, Katharina Rentsch, Chin B Eap, Pierre Baumann. Drug Saf 2006
52
100

Statin-associated muscle-related adverse effects: a case series of 354 patients.
Stephanie Cham, Marcella A Evans, Julie O Denenberg, Beatrice A Golomb. Pharmacotherapy 2010
75
100

A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.
Keith B Hoffman, Christina Kraus, Mo Dimbil, Beatrice A Golomb. PLoS One 2012
72
100

Drug-induced acid-base disorders.
Daniel Kitterer, Matthias Schwab, M Dominik Alscher, Niko Braun, Joerg Latus. Pediatr Nephrol 2015
30
100

Addressing phenoconversion: the Achilles' heel of personalized medicine.
Rashmi R Shah, Robert L Smith. Br J Clin Pharmacol 2015
147
100

Statin-induced fibrotic nonspecific interstitial pneumonia.
S Lantuejoul, E Brambilla, C Brambilla, G Devouassoux. Eur Respir J 2002
33
100

Statins and the risk of interstitial lung disease: a cohort study.
Nathalie Saad, Philippe Camus, Samy Suissa, Pierre Ernst. Thorax 2013
29
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.